• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Spatially defined intratumoral immune biomarkers predict recurrent versus second primary tumors in non-small cell lung cancer.

作者信息

Mudappathi Rekha, Maguire Alanna, Yi Eunhee S, Peng Yanmei, Kachergus Jennifer M, Khoor Andras, Tan Kexin, Zaniletti Isabella, Wampfler Jason A, Lou Yanyan, Reck Dos Santos Pedro A, D'Cunha Jonathan, Sun Zhifu, Liu Li, Jelinek Diane F, Wang Junwen, Tazelaar Henry D, Thompson E A, Yang Ping

机构信息

Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ 85259, USA.

College of Health Solutions, Arizona State University, Phoenix , AZ 85004, USA.

出版信息

Precis Clin Med. 2025 Jan 17;8(1):pbaf001. doi: 10.1093/pcmedi/pbaf001. eCollection 2025 Mar.

DOI:10.1093/pcmedi/pbaf001
PMID:40041422
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11878774/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/11878774/7832d383a606/pbaf001fig1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/11878774/7832d383a606/pbaf001fig1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/11878774/7832d383a606/pbaf001fig1a.jpg

相似文献

1
Spatially defined intratumoral immune biomarkers predict recurrent versus second primary tumors in non-small cell lung cancer.空间定义的肿瘤内免疫生物标志物可预测非小细胞肺癌中的复发性肿瘤与第二原发性肿瘤。
Precis Clin Med. 2025 Jan 17;8(1):pbaf001. doi: 10.1093/pcmedi/pbaf001. eCollection 2025 Mar.
2
Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancer.肿瘤细胞增殖与 I 期非小细胞肺癌中免疫检查点表达增强相关。
J Thorac Cardiovasc Surg. 2019 Sep;158(3):911-919.e6. doi: 10.1016/j.jtcvs.2019.04.084. Epub 2019 May 17.
3
18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.18F-FDG在原发性肿瘤中的摄取作为非小细胞肺癌瘤内淋巴管侵犯和淋巴结受累的预测指标：一项多中心研究分析
J Nucl Med. 2005 Feb;46(2):267-73.
4
Intratumoral Immune Cell Densities Are Associated with Lung Adenocarcinoma Gene Alterations.肿瘤内免疫细胞密度与肺腺癌基因突变相关。
Am J Respir Crit Care Med. 2016 Dec 1;194(11):1403-1412. doi: 10.1164/rccm.201510-2031OC.
5
IL-4 mediated TAP2 downregulation is a dominant and reversible mechanism of immune evasion and immunotherapy resistance in non-small cell lung cancer.白细胞介素-4介导的TAP2下调是非小细胞肺癌免疫逃逸和免疫治疗耐药的主要且可逆机制。
Mol Cancer. 2025 Mar 17;24(1):80. doi: 10.1186/s12943-025-02276-z.
6
Exosomal miRNAs as biomarkers of recurrent lung cancer.外泌体微小RNA作为复发性肺癌的生物标志物
Tumour Biol. 2016 Aug;37(8):10703-14. doi: 10.1007/s13277-016-4939-8. Epub 2016 Feb 11.
7
Evaluating peritumoral and intratumoral radiomics signatures for predicting lymph node metastasis in surgically resectable non-small cell lung cancer.评估瘤周和瘤内影像组学特征以预测可手术切除的非小细胞肺癌中的淋巴结转移
Front Oncol. 2024 Oct 11;14:1427743. doi: 10.3389/fonc.2024.1427743. eCollection 2024.
8
Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non-small cell lung cancers.T4N0M0（直径≥7cm）非小细胞肺癌中的肿瘤内遗传和免疫微环境异质性。
Thorac Cancer. 2022 May;13(9):1333-1341. doi: 10.1111/1759-7714.14393. Epub 2022 Apr 8.
9
Clinically validated model predicts the effect of intratumoral heterogeneity on overall survival for non-small cell lung cancer (NSCLC) patients.临床验证模型预测了肿瘤内异质性对非小细胞肺癌（NSCLC）患者总生存期的影响。
Comput Methods Programs Biomed. 2021 Nov;212:106455. doi: 10.1016/j.cmpb.2021.106455. Epub 2021 Oct 12.
10
Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma.免疫热点的空间定位反映了肺鳞状细胞癌中 B 细胞和 T 细胞的相互作用。
Cancer Res. 2023 May 2;83(9):1410-1425. doi: 10.1158/0008-5472.CAN-22-2589.

本文引用的文献

1
Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model.基于风险模型的肺癌幸存者第二原发性肺癌管理：使用验证的风险预测模型。
Cancer. 2024 Mar 1;130(5):770-780. doi: 10.1002/cncr.35069. Epub 2023 Oct 25.
2
Hot and cold tumors: Immunological features and the therapeutic strategies.冷热肿瘤：免疫特征与治疗策略
MedComm (2020). 2023 Aug 26;4(5):e343. doi: 10.1002/mco2.343. eCollection 2023 Oct.
3
Recurrence After Complete Resection for Non-Small Cell Lung Cancer in the National Lung Screening Trial.
国家肺癌筛查试验中完全切除后的非小细胞肺癌复发。
Ann Thorac Surg. 2023 Oct;116(4):684-692. doi: 10.1016/j.athoracsur.2023.06.004. Epub 2023 Jun 24.
4
Multiplex digital spatial profiling of proteins and RNA in fixed tissue.固定组织中蛋白质和 RNA 的多重数字空间分析。
Nat Biotechnol. 2020 May;38(5):586-599. doi: 10.1038/s41587-020-0472-9. Epub 2020 May 11.
5
Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers.纳入治疗前外周血标志物的非小细胞肺癌患者总生存预测列线图。
Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1214-1222. doi: 10.1093/ejcts/ezx462.
6
Intraclass correlation: Improved modeling approaches and applications for neuroimaging.组内相关系数：神经影像学的改进建模方法和应用。
Hum Brain Mapp. 2018 Mar;39(3):1187-1206. doi: 10.1002/hbm.23909. Epub 2017 Dec 7.
7
Second primary lung cancer.第二原发性肺癌
Ann Thorac Surg. 1995 Apr;59(4):863-6; discussion 867. doi: 10.1016/0003-4975(95)00067-u.